Table 1.
Search Strategy
| Databases | Query | Results |
|---|---|---|
| Medline (PubMed) | ||
| 1 | ((arthritis, rheumatoid[MeSH Terms]) AND (BIOSIMILAR[Title/Abstract])) OR (BIOSIMILARS[Title/Abstract]) | 2653 |
| 2 | ((arthritis, rheumatoid[MeSH Terms]) AND (BIOSIMILAR[Title/Abstract])) OR (BIOSIMILARS[Title/Abstract]) AND (clinicaltrial[Filter] OR randomizedcontrolledtrial[Filter] OR observationalstudy[Filter]) Filters: Clinical Trial, Observational Study, Randomized Controlled Trial, English, Spanish Sort by: Most Recent | 133 |
| 3 | ((“arthritis, rheumatoid”[MeSH Terms] AND “BIOSIMILAR”[Title/Abstract]) OR “BIOSIMILARS”[Title/Abstract]) AND (“clinical trial”[Publication Type] OR “randomized controlled trial”[Publication Type] OR “observational study”[Publication Type])) AND (english[Filter] OR spanish[Filter]) AND (alladult[Filter])) | 101 |
| 4 | (((arthritis, rheumatoid[MeSH Terms]) AND (biosimilars[Title/Abstract])) OR (biosimilar[Title/Abstract])) AND (patient-reported outcomes[Title/Abstract]) | 12 |
| Medline (OVID) | ||
| 1 | Rheumatoid arthritis.ti. and biosimilars.ab. | 113 |
| 2 | Limit 1 to “all adult (19 plus years)”.Limit 2 to humans | 53 |
| 3 | Buscar en todas las revistas de Ovid (Referencias + Abstracts + Revistas Suscritas)Buscar en revistas suscritas (Texto Completo) Buscar en Ovid Medline ACP Journal Club <1991 to December 2021> EBM Reviews - Cochrane Central Register of Controlled Trials <December 2021> ((rheumatoid arthritis.ti. and biosimilars.ab.) or BIOSIMILARS.kf.) and PATIENT-REPORTED OUTCOMES.af. |
8 |
| Scopus | ||
| 1 | TITLE-ABS-KEY (“rheumatoid arthritis”) AND TITLE-ABS-KEY (“biosimilars”) SUBJAREA (medi) | 711 |
| 2 | TITLE-ABS-KEY (“rheumatoid arthritis”) AND TITLE-ABS-KEY (“biosimilars”) SUBJAREA (medi) AND (LIMIT-TO (PUBYEAR, 2021) OR LIMIT-TO (PUBYEAR, 2020) OR LIMIT-TO (PUBYEAR, 2019) OR LIMIT-TO (PUBYEAR, 2018) OR LIMIT-TO (PUBYEAR, 2017) OR LIMIT-TO (PUBYEAR, 2016) OR LIMIT-TO (PUBYEAR, 2015) OR LIMIT-TO (PUBYEAR, 2014) OR LIMIT-TO (PUBYEAR, 2013)) AND (LIMITTO (DOCTYPE, “ar”)) AND (LIMIT-TO (LANGUAGE, “English”) OR LIMIT TO (LANGUAGE, “Spanish”)) AND (LIMIT-TO (SRCTYPE, “j”)) | 347 |
| 3 | TITLE-ABS-KEY (“rheumatoid arthritis”) AND TITLE-ABS-KEY (“Patient-reported outcomes”) AND TITLE-ABS-KEY (“biosimilar”) SUBJAREA (medi) | 12 |
| CINAHL (EBSCO host) | ||
| 1 | TI rheumatoid arthritis AND AB biosimilars OR AB biosimilar. | 1099 |
| 2 | TI rheumatoid arthritis AND AB biosimilars OR AB biosimilar. Limiters - Published Date: 20120101–20211231; English Language; Peer Reviewed; Research Article; Randomized Controlled Trials; Age Groups: All Adult. | 42 |
| 3 | TI rheumatoid arthritis AND AB biosimilars OR MW biosimilars AND Patient-reported ocutcomes.Limiters. Published Date: 20130101–20211231. English Language. Peer Reviewed. Research Article. Human. Age Groups: All Adult | 10 |
| Lilacs | ||
| 1 | Artritis reumatoide [Palabras] and biosimilares [Palabras] or biocomparables [Palabras] | 4 |